New CureTalks program on modern forms of prostate imaging

Our next CureTalks program will be on the evolving role of imaging in the diagnosis and management of prostate cancer on Thursday, July 27, at 5:00 p.m. Pacific / 8:00 p.m. Eastern time. … READ MORE …

FDA accepts NDA for new formulation of abiraterone acetate

In  January and May this year we had noted that a company called Churchill Pharmaceuticals has been developing a different formulation of ultramicron-sized, oral abiraterone acetate (to be called Yonsa™). … READ MORE …

Vasectomy and risk for prostate cancer (for hopefully the last time!)

Your sitemaster sincerely hopes that this is indeed going to be the very last time he will ever have to deal with this topic. He’s been saying much the same thing for nearly 30 years now! … READ MORE …

“Active surveillance: protecting patients from harm”

If you want to get a current update on the management of patients on active surveillance, you need to listed to/watch this presentation by Dr. Lawrence Klotz on the UroToday web site. But you will need 45 minutes. … READ MORE …

How close are we really to “precision medicine” for cancer care?

A newly published paper in the journal JCO Precision Oncology confirms what many of us may have suspected — that the practical application of somatic tissue testing to clinical decision-making was low prior to 2015 . … READ MORE …

On “Speaking the unspoken”

In his blog post from July 4 that just came to our attention, Dr. Craig Hildreth has (once again) hit the nail right on the head. There really are some physicians with truly outstanding communication skills!

Treating the psychosocial and emotional impact of prostate cancer

It doesn’t take too much reading or direct experience to realize that, to date, we haven’t been very good at meeting the needs of patients with prostate cancer — or their spouses/partners — when it comes to the sociocultural and psychological needs associated with this disorder. … READ MORE …